書誌情報

GL-1. Perioperative pembrolizumab (pembro) for early-stage NSCLC : east Asian subgroup of KEYNOTE-671

Terufumi Kato1, Hisashi Saji2, Morihito Okada3, Shugeng Gao4, Ke-Neng Chen5, Se-Hoon Lee6, Tao Jiang7, Yuming Zhu8, Lijie Tan9, Ji-Youn Han10, Hsu-Ching Huang11, Heather Wakelee12, Jonathan D Spicer13, Erin Jensen14, Steven M Keller14, Ayman Samkari14, Masahiro Tsuboi15
1Kanagawa Cancer Center, 2St Marianna University School of Medicine, 3Hiroshima University, 4National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 5Beijing Cancer Hospital, Peking University, 6Samsung Medical Center, Sungkyunkwan University School of Medicine, 7Tangdu Hospital, Air Force Medical University, 8Shanghai Pulmonary Hospital, Tongji University School of Medicine, 9Zhongshan Hospital of Fudan University, 10National Cancer Center, Gyeonggi-do, 11Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, 12Stanford University School of Medicine / Stanford Cancer Institute, 13McGill University Health Centre, 14Merck & Co., Inc., 15National Cancer Center Hospital East
Japanese Journal of Lung Cancer 63(5): 357-357, 2023.

個人会員・法人会員の方(IDが5または10で始まる方)

  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。

ライブラリー会員の方(IDが11または12で始まる方)